Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
148.9 USD | +0.25% | +3.00% | -4.98% |
12:45pm | Tylenol maker Kenvue beats quarterly profit estimates, to cut 4% jobs | RE |
May. 06 | J&J: encouraging results in prostate cancer | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.98% | 358B | |
+32.95% | 690B | |
+26.43% | 546B | |
+18.13% | 323B | |
+4.55% | 287B | |
+14.32% | 235B | |
+5.79% | 199B | |
-9.49% | 195B | |
+4.00% | 161B | |
-2.85% | 159B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Johnson & Johnson Says Europe's CHMP Recommends Approval of Rybrevant Plus Chemotherapy for Lung Cancer Treatment